Recent Progress in Immunotherapy for RRMM: Updates from EHA 2023 Congress by María-Victoria Mateos

Get full text

TREATMENT AT RELAPSE: WHAT TO DO FIRST? by Maria-Victoria Mateos

Get full text

Can multiple myeloma become a curable disease? by Jesús F. San-Miguel, María-Victoria Mateos

Get full text

Anti-BCMA CAR T-cell Therapy: Changing the Natural History of Multiple Myeloma by Borja Puertas, María-Victoria Mateos, Verónica González-Calle

Get full text

Smoldering multiple myeloma current treatment algorithms by S. Vincent Rajkumar, Shaji Kumar, Sagar Lonial, Maria Victoria Mateos

Get full text

Correction: Clinical evidence for immune-based strategies in early-line multiple myeloma: current challenges in decision-making for subsequent therapy by Noopur Raje, María-Victoria Mateos, Shinsuke Iida, Donna Reece

Get full text

Clinical evidence for immune-based strategies in early-line multiple myeloma: current challenges in decision-making for subsequent therapy by Noopur Raje, María-Victoria Mateos, Shinsuke Iida, Donna Reece

Get full text

RELAPSED/REFRACTORY MULTIPLE MYELOMA: THE CURRENT STATE OF PLAY by María-Victoria Mateos, Enrique M. Ocio, Verónica González, Julio Dávila

Get full text

Antibiotic Resistance: The Silent Pandemia (in the COVID-19 Era) by Angel-Orión Salgado Peralvo, Naresh Kewalramani, María-Victoria Mateos-Moreno

Get full text

PB2131: MAGNETISMM-7: AN OPEN-LABEL, MULTICENTER, RANDOMIZED PHASE 3 STUDY OF ELRANATAMAB VERSUS LENALIDOMIDE IN POST-TRANSPLANT PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA by Maria Victoria Mateos Manteca, Sebastian Grosicki, Kihyun Kim, Eric Negre, Erik Vandendries

Get full text

P967: A MACHINE LEARNING MODEL FOR RISK PREDICTION IN MULTIPLE MYELOMA PROGRESSING AFTER THE FIRST LINE OF THERAPY by Adrian Mosquera-Orgueira, Marta Sonia Gonzalez Perez, Jose Angel Diaz Arias, Maria-Victoria Mateos

Get full text

Prognostic Stratification of Multiple Myeloma Using Clinicogenomic Models: Validation and Performance Analysis of the IAC-50 Model by Adrián Mosquera Orgueira, Marta Sonia González Pérez, José Ángel Díaz Arias, Beatriz Antelo Rodríguez, María-Victoria Mateos

Get full text

Mass Spectrometry as Alternative Method to Identify and Monitor Non-Secretory Progressive Disease in Patients with Multiple Myeloma by Cristina Agulló, Noemí Puig, Teresa Contreras, Sergio Castro, Borja Puertas, Verónica González-Calle, Beatriz Rey-Búa, María Victoria Mateos

Get full text

Response and progression-free survival according to planned treatment duration in patients with relapsed multiple myeloma treated with carfilzomib, lenalidomide, and dexamethasone... by Meletios Dimopoulos, Michael Wang, Vladimir Maisnar, Jiri Minarik, William Bensinger, Maria-Victoria Mateos, Mihaela Obreja, Julie Blaedel, Philippe Moreau

Get full text

Global disparities in patients with multiple myeloma: a rapid evidence assessment by Maria-Victoria Mateos, Sikander Ailawadhi, Luciano J. Costa, Shakira J. Grant, Lalit Kumar, Mohamad Mohty, Didem Aydin, Saad Z. Usmani

Get full text

Drug-induced Thrombotic Microangiopathy During Maintenance Treatment in a Patient With Multiple Myeloma by Víctor Higuero Saavedra, Verónica González-Calle, Eduardo Sobejano, Josefa Sebastiá, Mónica Cabrero, Jose María Bastida, Noemi Puig, Enrique M. Ocio, María-Victoria Mateos

Get full text

The clinical journey of belantamab mafodotin in relapsed or refractory multiple myeloma: lessons in drug development by Pralay Mukhopadhyay, Hesham A. Abdullah, Joanna B. Opalinska, Prani Paka, Eric Richards, Katja Weisel, Suzanne Trudel, Maria-Victoria Mateos, Meletios Athanasios Dimopoulos, Sagar Lonial

Get full text

Myelodysplasia-associated immunophenotypic alterations of bone marrow cells in myeloma: are they present at diagnosis or are they induced by lenalidomide? by Sergio Matarraz, Bruno Paiva, María Diez-Campelo, Lucia-López Corral, Estefanía Pérez, Maria-Victoria Mateos, Pilar Giraldo, Miguel T. Hernández, Jesús F. San Miguel, Alberto Orfao

Get full text

Matching‐adjusted indirect comparison of efficacy and safety of bortezomib, thalidomide, and dexamethasone (VTd) as per label compared with modified VTd dosing schedules in patient... by Pieter Sonneveld, María‐Victoria Mateos, Adrian Alegre, Thierry Facon, Cyrille Hulin, Mahmoud Hashim, Talitha Vincken, Tobias Kampfenkel, Sarah Cote, Jianming He, Annette Lam, Philippe Moreau

Get full text

Multiple myeloma with t(11;14): impact of novel agents on outcome by Borja Puertas, Verónica González-Calle, Eduardo Sobejano-Fuertes, Fernando Escalante, Beatriz Rey-Bua, Irene Padilla, Ramón García-Sanz, Noemi Puig, Norma C. Gutiérrez, María-Victoria Mateos

Get full text